Login / Signup

Oral oxycodone/naloxone for pain control in cirrhosis: Observational study in patients with symptomatic metastatic hepatocellular carcinoma.

Francesco TovoliStefania De LorenzoBoaz Gedaliahu Samolsky DekelPiscaglia FabioFrancesca BeneventoGiovanni BrandiLuigi Bolondi
Published in: Liver international : official journal of the International Association for the Study of the Liver (2017)
OXN may be considered a safe and effective option in the fragile population of cirrhotic patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • chronic pain
  • squamous cell carcinoma
  • pain management
  • neuropathic pain
  • spinal cord
  • spinal cord injury
  • patient reported outcomes